New study brings HIV prevention directly to Nigeria's minibus drivers
NCT ID NCT07000513
First seen May 18, 2026 · Last updated May 24, 2026 · Updated 1 time
Summary
This study aims to help 400 male commercial minibus drivers in Nigeria access HIV self-testing and long-acting injectable medications for both HIV treatment and prevention. The program uses peer educators from the driver community to promote these tools, making it easier for drivers who rarely visit clinics to protect themselves and manage their health.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
National Institute of Medical Research
Lagos, Lagos, Nigeria
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.